Anebulo Pharmaceuticals, Inc. (ANEB) — 10-K Filings
All 10-K filings from Anebulo Pharmaceuticals, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Anebulo Zero Revenue, Eyes Cannabis Toxicity Treatment Amid Go-Private Plan
— Sep 29, 2025 Risk: high
Anebulo Pharmaceuticals, Inc. (ANEB) reported no revenue since its inception and anticipates future losses, indicating a pre-commercial stage. The company's pri -
Anebulo Pharmaceuticals Files 2024 Annual Report
— Sep 25, 2024 Risk: medium
Anebulo Pharmaceuticals, Inc. filed its annual report for the fiscal year ended June 30, 2024. The company is registered in Delaware and its common stock trades
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX